Showing posts with label Digital Therapeutics Market Share. Show all posts
Showing posts with label Digital Therapeutics Market Share. Show all posts

Tuesday, 12 October 2021

Digital Therapeutics Market With Business Strategies And Analysis To 2028

 Digital Therapeutics The global digital therapeutics market size is expected to reach USD 13.51 billion by 2028 according to a new study by Polaris Market Research. The report “Global Digital Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Application (Diabetes, Obesity, CVD, CNS Disease, Respiratory Diseases, Smoking Cessation, Others), By End-Use (Patients, Providers, Payers, Employers, Others), By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The distinction between digital therapeutics is determined by patient clinical outcomes. Digital therapeutics do not use market-based health-related instruments like step and calorie-counters. It is a modern form of healthcare product that utilizes digital technologies to avoid, handle, and health ailments. Furthermore, it makes use of emerging health technology to treat the psychiatric ailment. As a result, the aforementioned factors contribute to the growth of the target market share.

 

During the year 2020, digital health went from innovation to need. As acceptance peaked, exacerbated by the COVID-19 pandemic, it swept into almost every healthcare domain. Telehealth, digital pathology, triage solutions, telemedicine, mhealth, and digital therapeutics were among the topics discussed.

 

Request for sample of this research report @ https://www.polarismarketresearch.com/industry-analysis/digital-therapeutics-market/request-for-sample

 

Digital Therapeutics Market Analysis & Segment Forecast till 2028

Omada Health, Inc., took advantage of the shortages in treatment caused by COVID-19 to offer additional help and advice through its dedicated practitioners to those whose doctor’s appointments had been postponed indefinitely.

 

Additionally, the organization assisted primary care practitioners, psychiatrists, endocrinologists, and cardiologists in converting their practices to telehealth through providing improved knowledge, psychosocial support, and an online platform.

 

Market participants such as 2Morrow, Inc., Akili Interactive Labs, Ayogo Health Inc., Better Therapeutics, Inc., Canary Health Inc., Click Therapeutics, Inc., Cognoa, Inc., Ginger, Kaia Health Software GmbH, Livongo Health Inc, Mango Health, Inc., Mindstrong Inc., Noom Health, Inc., Omada Health, Inc., Otsuka America Pharmaceutical, Inc., Pear Therapeutics, Inc., Propeller Health, WellDoc, Inc., and Wellthy Therapeutics are some of the companies operating in the market for digital therapeutics.

 

The FDA issued recommendations extending and encouraging the scope of digital health therapeutics technologies for mental health issues in response to COVID-19 and its ramifications on mental health. Another factor expected to drive demand growth is increased public and private sector initiatives. For example, Akili Interactive Labs, Inc. obtained the CE mark for EndeavorRx, its digital therapeutics software for the treatment of ADHD, in June 2020.

 

Get Exclusive Discount on This Report @ https://www.polarismarketresearch.com/industry-analysis/digital-therapeutics-market/request-for-discount-pricing

 

Digital therapeutics is anticipated to rise at a steady pace in the given timeframe, due to strong internet usage and reliance on smartphones. This is due to a rise in demand for creative and innovative treatment solutions that patients can access remotely.

 

In February 2021, SilverCloud and Cerner Corporation collaborated to combine SilverCloud’s virtual mental health network with Cerner’s electronic health records. SilverCloud hoped that by doing so, it would be able to scale the delivery of evidence-based mental health services while both enhancing patient outcomes and lowering healthcare costs.

 

Polaris Market Research has segmented the digital therapeutics market report based on application, end-use, and region:

 

Digital Therapeutics, Application Outlook (Revenue – USD Billion, 2016 – 2028)

  • Diabetes
  • Obesity
  • CVD
  • CNS Disease
  • Respiratory Diseases
  • Smoking Cessation
  • Others

Digital Therapeutics, End-Use Outlook (Revenue – USD Billion, 2016 – 2028)

  • Patients
  • Providers
  • Payers
  • Employers
  • Others

Read :

https://www.prnewswire.com/news-releases/terminal-sterilization-services-market-size-to-reach-18-97-billion-by-2028--cagr-10-4-polaris-market-research-301387749.html

https://www.prnewswire.com/news-releases/food-waste-management-market-size-worth-54-29-billion-by-2028--cagr-5-6-polaris-market-research-301387793.html

 

Wednesday, 29 September 2021

Digital Therapeutics Market Size, Recent Advancement & Scope Top Trends

 PDF :  Digital Therapeutics Market  2021 – 2028 


The global digital therapeutics market size is expected to reach USD 13.51 billion by 2028 according to a new study by Polaris Market Research. The report “Global Digital Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Application (Diabetes, Obesity, CVD, CNS Disease, Respiratory Diseases, Smoking Cessation, Others), By End-Use (Patients, Providers, Payers, Employers, Others), By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth. 

 

The distinction between digital therapeutics is determined by patient clinical outcomes. Digital therapeutics do not use market-based health-related instruments like step and calorie-counters. It is a modern form of healthcare product that utilizes digital technologies to avoid, handle, and health ailments. Furthermore, it makes use of emerging health technology to treat the psychiatric ailment. As a result, the aforementioned factors contribute to the growth of the target market share.

 

During the year 2020, digital health went from innovation to need. As acceptance peaked, exacerbated by the COVID-19 pandemic, it swept into almost every healthcare domain. Telehealth, digital pathology, triage solutions, telemedicine, mhealth, and digital therapeutics were among the topics discussed.

 

Request for sample of this research report @ https://www.polarismarketresearch.com/industry-analysis/digital-therapeutics-market/request-for-sample

 

Omada Health, Inc., took advantage of the shortages in treatment caused by COVID-19 to offer additional help and advice through its dedicated practitioners to those whose doctor’s appointments had been postponed indefinitely.

 

Additionally, the organization assisted primary care practitioners, psychiatrists, endocrinologists, and cardiologists in converting their practices to telehealth through providing improved knowledge, psychosocial support, and an online platform.

 

Market participants such as 2Morrow, Inc., Akili Interactive Labs, Ayogo Health Inc., Better Therapeutics, Inc., Canary Health Inc., Click Therapeutics, Inc., Cognoa, Inc., Ginger, Kaia Health Software GmbH, Livongo Health Inc, Mango Health, Inc., Mindstrong Inc., Noom Health, Inc., Omada Health, Inc., Otsuka America Pharmaceutical, Inc., Pear Therapeutics, Inc., Propeller Health, WellDoc, Inc., and Wellthy Therapeutics are some of the companies operating in the market for digital therapeutics.

 

The FDA issued recommendations extending and encouraging the scope of digital health therapeutics technologies for mental health issues in response to COVID-19 and its ramifications on mental health. Another factor expected to drive demand growth is increased public and private sector initiatives. For example, Akili Interactive Labs, Inc. obtained the CE mark for EndeavorRx, its digital therapeutics software for the treatment of ADHD, in June 2020.

 

Get Exclusive Discount on This Report @ https://www.polarismarketresearch.com/industry-analysis/digital-therapeutics-market/request-for-discount-pricing 

 

Digital therapeutics is anticipated to rise at a steady pace in the given timeframe, due to strong internet usage and reliance on smartphones. This is due to a rise in demand for creative and innovative treatment solutions that patients can access remotely.

 

In February 2021, SilverCloud and Cerner Corporation collaborated to combine SilverCloud’s virtual mental health network with Cerner’s electronic health records. SilverCloud hoped that by doing so, it would be able to scale the delivery of evidence-based mental health services while both enhancing patient outcomes and lowering healthcare costs.

 

Polaris Market Research has segmented the digital therapeutics market report based on application, end-use, and region:

 

Digital Therapeutics, Application Outlook (Revenue – USD Billion, 2016 – 2028)

  • Diabetes
  • Obesity
  • CVD
  • CNS Disease
  • Respiratory Diseases
  • Smoking Cessation
  • Others

Digital Therapeutics, End-Use Outlook (Revenue – USD Billion, 2016 – 2028)

  • Patients
  • Providers
  • Payers
  • Employers
  • Others

 

Thursday, 2 September 2021

Digital Therapeutics Market With Business Strategies And Analysis To 2028

 The global digital therapeutics market size is expected to reach USD 13.51 billion by 2028 according to a new study by Polaris Market Research. The report “Global Digital Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Application (Diabetes, Obesity, CVD, CNS Disease, Respiratory Diseases, Smoking Cessation, Others), By End-Use (Patients, Providers, Payers, Employers, Others), By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

 

 

The distinction between digital therapeutics is determined by patient clinical outcomes. Digital therapeutics do not use market-based health-related instruments like step and calorie-counters. It is a modern form of healthcare product that utilizes digital technologies to avoid, handle, and health ailments. Furthermore, it makes use of emerging health technology to treat the psychiatric ailment. As a result, the aforementioned factors contribute to the growth of the target market share.

 

During the year 2020, digital health went from innovation to need. As acceptance peaked, exacerbated by the COVID-19 pandemic, it swept into almost every healthcare domain. Telehealth, digital pathology, triage solutions, telemedicine, mhealth, and digital therapeutics were among the topics discussed.

 

Request for sample of this research report @ https://www.polarismarketresearch.com/industry-analysis/digital-therapeutics-market/request-for-sample

 

Omada Health, Inc., took advantage of the shortages in treatment caused by COVID-19 to offer additional help and advice through its dedicated practitioners to those whose doctor’s appointments had been postponed indefinitely.

 

Additionally, the organization assisted primary care practitioners, psychiatrists, endocrinologists, and cardiologists in converting their practices to telehealth through providing improved knowledge, psychosocial support, and an online platform.

 

Market participants such as 2Morrow, Inc., Akili Interactive Labs, Ayogo Health Inc., Better Therapeutics, Inc., Canary Health Inc., Click Therapeutics, Inc., Cognoa, Inc., Ginger, Kaia Health Software GmbH, Livongo Health Inc, Mango Health, Inc., Mindstrong Inc., Noom Health, Inc., Omada Health, Inc., Otsuka America Pharmaceutical, Inc., Pear Therapeutics, Inc., Propeller Health, WellDoc, Inc., and Wellthy Therapeutics are some of the companies operating in the market for digital therapeutics.

 

The FDA issued recommendations extending and encouraging the scope of digital health therapeutics technologies for mental health issues in response to COVID-19 and its ramifications on mental health. Another factor expected to drive demand growth is increased public and private sector initiatives. For example, Akili Interactive Labs, Inc. obtained the CE mark for EndeavorRx, its digital therapeutics software for the treatment of ADHD, in June 2020.

 

Get Exclusive Discount on This Report @ https://www.polarismarketresearch.com/industry-analysis/digital-therapeutics-market/request-for-discount-pricing 

 

Digital therapeutics is anticipated to rise at a steady pace in the given timeframe, due to strong internet usage and reliance on smartphones. This is due to a rise in demand for creative and innovative treatment solutions that patients can access remotely.

 

In February 2021, SilverCloud and Cerner Corporation collaborated to combine SilverCloud’s virtual mental health network with Cerner’s electronic health records. SilverCloud hoped that by doing so, it would be able to scale the delivery of evidence-based mental health services while both enhancing patient outcomes and lowering healthcare costs.

 

Polaris Market Research has segmented the digital therapeutics market report based on application, end-use, and region:

 

Digital Therapeutics, Application Outlook (Revenue – USD Billion, 2016 – 2028)

  • Diabetes
  • Obesity
  • CVD
  • CNS Disease
  • Respiratory Diseases
  • Smoking Cessation
  • Others

Digital Therapeutics, End-Use Outlook (Revenue – USD Billion, 2016 – 2028)

  • Patients
  • Providers
  • Payers
  • Employers
  • Others

 

Monday, 23 August 2021

Aircraft Fairings Market With Business Strategies And Analysis To 2028

 Aircraft Fairings | 2021 Scope Of Current And Future Industry 


The global aircraft fairings market size is expected to reach USD 1,713.1 million by 2026 according to a new study by Polaris Market Research. An aircraft fairing is an essential structure which manages and the flow of the airplane body in different directions and axes with reducing the various types of drags such as wave drag, interference drag, parasitic drag, engine cooling- drag and other types of drag. The implementation and functional characteristics play a critical role in design, certification and operational aspects of all narrow-body, wide-body, very large, regional and general aviation. These structures directly affect the performance of an airliner as compared to any other old generation airplane without these structures. In other words, airplane fairings are the smooth structures for reducing the air drag between the joints such as wings & fuselage and engine & wings during the flight.

 

Get Sample PDF @ https://www.polarismarketresearch.com/industry-analysis/aircraft-fairings-market/request-for-sample

 

Fairings are an essential feature of all airplanes as it reduces the drag at most of the areas of airplane body, reduces the roughness of the body surface, increases the smoothness by covering the gaps between the joints of structures, provides an external outline to the aerodynamic structure of the airliner and increases the speed and its efficiency. The complexity of aerospace fairings depends on several parameters including the type of jet, design, fairing application areas, and number of fairings. For instance, General aviation airliners have lesser complex fairings, whereas long haul/commercial jets usually have more complex fairings addressing the aircraft’s application requirements.

 

According to Polaris market Research, the global market for airplane fairings has less than 90 players throughout the world, wherein top 5 major players accounted for a market share of more than 50% in 2019. Companies such as Composite Technology Research Malaysia (CTRM Aerocomposites Sdn Bhd), FACC AG, Finmeccanica-Alenia Aermacchi S.p.A., KAMAN CORPORATION, Korean Air Aerospace Division, Malibu Aerospace LLC, Royal Engineered Composites, ShinMaywa Industries Ltd., Spirit AeroSystems Inc., Strata Manufacturing (a Mubadala Investment Company), Triumph Group, Collins Aerospace (UTC Aerospace Systems) are some of the key players operating in this market. 

 

Rise in global airplanes fleet size, rising demand to streamline aerodynamic structure of jets to boost speed & accuracy, growing global commercial aircraft & general aviation deliveries, introduction of new generation carriers and increasing trend of lightweight components in order to reduce overall weight & increase the fuel efficiency by reducing operational costs, are some of the major factors acting as key drivers of this market.

 

Get Special Discount On this Research Report @ https://www.polarismarketresearch.com/industry-analysis/aircraft-fairings-market/request-for-discount-pricing

 

Among aircraft type, wide-body airplane was estimated to be the largest sub-segment in 2019 and is expected to be the largest during the forecast period as well followed by narrow-body aircraft and very large aircraft sub-segments. This is owing to increasing production and rising demand of wide-body airliner such as A320, B787, B737 and others. Moreover, Airbus anticipated that approximately 34,900 commercial airplanes (narrow-body, wide-body, and very large) will be delivered during 2017 to 2036. A320 family, B737, B787, and A350XWB would remain the growth engines for the commercial airplane segment.

 

Among material type, composites accounted for the largest share in 2019 and is expected to be the largest segment during the forecast period as well. Also, composites are expected to be the fastest growing material type for airplane fairings during the forecast period owing to increasing demand of lightweight components for airplane structures along with long endurance and less maintenance.

 

Have Questions? Speak to our Industry Expert @  https://www.polarismarketresearch.com/industry-analysis/aircraft-fairings-market/speak-to-analyst

 

Among manufacturing process type, prepreg layup process was estimated to be the largest sub-segment in 2019 and is projected to be most dominant during the forecast period as well. Also, its is expected to be the fastest growing manufacturing process type for aircraft fairings during the forecast period as well owing to its higher suitability for the composite fabrication and highly preferred method for complex structure for fairings parts. Higher preference towards the prepreg layup by the commercial, general aviation and regional airplane OEMs; increasing production rates of commercial jets, such as B787, A350XWB, and B737; upcoming or the new variants of existing aircraft such as Bombardier C Series and Embraer E-2 jets; and rising airplane fleet size are the major growth drivers of prepreg layup process for the manufacturing of the fairing components globally.

 

Among region, North America was estimated to be the largest region in 2019 and is also expected to be remain the largest during the forecast period as well. The U.S. is growth engine of this region and accounted for more than 90% of share in the North American market in 2019. This is owing to large presence of small to mid-sized airplanes OEMs, fairing component manufacturers, raw material suppliers, & distributors. In addition, increasing production rates of the airliner models such as B737, B737 Max, B787, B797, B777x, and combat jet such as F-35 is another major factor aiding in the growth of this market in the region.

 

Buy Now : https://www.polarismarketresearch.com/checkouts/6281

Digital Therapeutics Market Overview, Trends Forecast Analysis By Top Manufactures

 Digital Therapeutics | 2021 Scope Of Current And Future Industry 


The global digital therapeutics market size is expected to reach USD 13.51 billion by 2028 according to a new study by Polaris Market Research. The report “Global Digital Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Application (Diabetes, Obesity, CVD, CNS Disease, Respiratory Diseases, Smoking Cessation, Others), By End-Use (Patients, Providers, Payers, Employers, Others), By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

  

The distinction between digital therapeutics is determined by patient clinical outcomes. Digital therapeutics do not use market-based health-related instruments like step and calorie-counters. It is a modern form of healthcare product that utilizes digital technologies to avoid, handle, and health ailments. Furthermore, it makes use of emerging health technology to treat the psychiatric ailment. As a result, the aforementioned factors contribute to the growth of the target market share.

 

During the year 2020, digital health went from innovation to need. As acceptance peaked, exacerbated by the COVID-19 pandemic, it swept into almost every healthcare domain. Telehealth, digital pathology, triage solutions, telemedicine, mhealth, and digital therapeutics were among the topics discussed.

 

Request for sample of this research report @ https://www.polarismarketresearch.com/industry-analysis/digital-therapeutics-market/request-for-sample

 

Omada Health, Inc., took advantage of the shortages in treatment caused by COVID-19 to offer additional help and advice through its dedicated practitioners to those whose doctor’s appointments had been postponed indefinitely.

 

Additionally, the organization assisted primary care practitioners, psychiatrists, endocrinologists, and cardiologists in converting their practices to telehealth through providing improved knowledge, psychosocial support, and an online platform.

 

Market participants such as 2Morrow, Inc., Akili Interactive Labs, Ayogo Health Inc., Better Therapeutics, Inc., Canary Health Inc., Click Therapeutics, Inc., Cognoa, Inc., Ginger, Kaia Health Software GmbH, Livongo Health Inc, Mango Health, Inc., Mindstrong Inc., Noom Health, Inc., Omada Health, Inc., Otsuka America Pharmaceutical, Inc., Pear Therapeutics, Inc., Propeller Health, WellDoc, Inc., and Wellthy Therapeutics are some of the companies operating in the market for digital therapeutics.

 

The FDA issued recommendations extending and encouraging the scope of digital health therapeutics technologies for mental health issues in response to COVID-19 and its ramifications on mental health. Another factor expected to drive demand growth is increased public and private sector initiatives. For example, Akili Interactive Labs, Inc. obtained the CE mark for EndeavorRx, its digital therapeutics software for the treatment of ADHD, in June 2020.

 

Get Exclusive Discount on This Report @ https://www.polarismarketresearch.com/industry-analysis/digital-therapeutics-market/request-for-discount-pricing 

 

Digital therapeutics is anticipated to rise at a steady pace in the given timeframe, due to strong internet usage and reliance on smartphones. This is due to a rise in demand for creative and innovative treatment solutions that patients can access remotely.

 

In February 2021, SilverCloud and Cerner Corporation collaborated to combine SilverCloud’s virtual mental health network with Cerner’s electronic health records. SilverCloud hoped that by doing so, it would be able to scale the delivery of evidence-based mental health services while both enhancing patient outcomes and lowering healthcare costs.

 

Polaris Market Research has segmented the digital therapeutics market report based on application, end-use, and region:

 

Digital Therapeutics, Application Outlook (Revenue – USD Billion, 2016 – 2028)

  • Diabetes
  • Obesity
  • CVD
  • CNS Disease
  • Respiratory Diseases
  • Smoking Cessation
  • Others

Digital Therapeutics, End-Use Outlook (Revenue – USD Billion, 2016 – 2028)

  • Patients
  • Providers
  • Payers
  • Employers
  • Others